{{Rsnum
|rsid=16754
|Gene=WT1
|Chromosome=11
|position=32396399
|Orientation=minus
|GMAF=0.3223
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=WT1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 72.6 | 25.7 | 1.8
| HCB | 6.7 | 37.0 | 56.3
| JPT | 13.4 | 49.1 | 37.5
| YRI | 77.2 | 20.0 | 2.8
| ASW | 78.6 | 21.4 | 0.0
| CHB | 6.7 | 37.0 | 56.3
| CHD | 11.0 | 41.3 | 47.7
| GIH | 35.6 | 51.5 | 12.9
| LWK | 82.6 | 16.5 | 0.9
| MEX | 44.8 | 39.7 | 15.5
| MKK | 75.6 | 24.4 | 0.0
| TSI | 70.3 | 28.7 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20038731
|Title=Single Nucleotide Polymorphism in the Mutational Hotspot of WT1 Predicts a Favorable Outcome in Patients With Cytogenetically Normal Acute Myeloid Leukemia
}}

{{PMID Auto
|PMID=20368538
|Title=Impact of IDH1 R132 Mutations and an IDH1 Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse Prognostic Factor
}}
{{PMID Auto
|PMID=21189390
|Title=WT1 Synonymous SNP rs16754 Correlates With Higher mRNA Expression and Predicts Significantly Improved Outcome in Favorable-Risk Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group
|OA=1
}}

{{PMID Auto
|PMID=21372155
|Title=Integrative prognostic risk score in acute myeloid leukemia with normal karyotype
}}

{{PMID Auto
|PMID=21659357
|Title=Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
|OA=1
}}

{{PMID Auto
|PMID=22015946
|Title=Single nucleotide polymorphism of Wilms' tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia
}}

{{PMID Auto
|PMID=22506617
|Title=WT1 Mutations and Single Nucleotide Polymorphism rs16754 Analysis of Patients with Pediatric Acute Myeloid Leukemia in a Chinese Population
}}

{{PMID Auto
|PMID=22568493
|Title=ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemia
}}

{{PMID|15687485}} Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population.

{{PMID|17267408|OA=1
}} Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells.

{{PMID|19914700}} Single-nucleotide polymorphism in WT1 gene in a hyperplastic intralobar nephrogenic rest with botryoid protrusion.

{{PMID|20644087}} No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia.

{{PMID|21760594}} Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia.

{{PMID|21798259}} WT1 mutations and polymorphisms in Southeast Asian acute myeloid leukemia.

{{PMID Auto
|PMID=23484026
|Title=Single Nucleotide Polymorphisms in the Wilms' Tumour Gene 1 in Clear Cell Renal Cell Carcinoma
|OA=1
}}

{{PMID Auto
|PMID=23956224
|Title=The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: Report from the Children's Oncology Group
}}

{{PMID Auto
|PMID=22895555
|Title=Analysis of mutational status, SNP rs16754, and expression levels of Wilms tumor 1 (WT1) gene in acute promyelocytic leukemia.
}}

{{PMID Auto
|PMID=23070125
|Title=Analysis of SNP rs16754 of WT1 gene in a series of de novo acute myeloid leukemia patients.
}}

{{PMID Auto
|PMID=23117548
|Title=WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.
}}

{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}